Il y a eu 50 transactions d'initiés récentes enregistrées pour Eliem Therapeutics, Inc. (ELYM), dont 28 achats et 19 ventes. Le total des achats d'initiés s'élève à $757.2K et le total des ventes d'initiés à $3.17M.
Les initiés notables ayant une activité récente comprennent Pimblett Emily, Kaplan Brett, Morisset Valerie. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ELYM
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-09-20 |
Pimblett Emily |
Chief Accounting Officer |
Vente Informative |
9 |
$8.06 |
$72.54 |
7,564 |
| 2024-09-18 |
Pimblett Emily |
Chief Accounting Officer |
Exercice d'Options |
5,000 |
- |
- |
8,755 |
| 2024-08-26 |
Kaplan Brett |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-08-26 |
Kaplan Brett |
Chief Operating Officer |
Attribution de RSU |
77,500 |
- |
- |
77,500 |
| 2024-07-22 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
30,000 |
$7.98 |
$239.4K |
31,317 |
| 2024-07-19 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
50,000 |
$7.24 |
$362K |
100,322 |
| 2024-07-18 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
38,576 |
$6.93 |
$267.33K |
160,523 |
| 2024-07-17 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
3,207 |
$6.91 |
$22.16K |
199,099 |
| 2024-07-16 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
50,000 |
$7.13 |
$356.5K |
202,306 |
| 2024-07-15 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
42,377 |
$7.01 |
$297.06K |
252,306 |
| 2024-07-12 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
50,000 |
$7.07 |
$353.5K |
294,683 |
| 2024-07-11 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
50,000 |
$7.11 |
$355.5K |
344,683 |
| 2024-07-10 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
50,000 |
$6.83 |
$341.5K |
394,683 |
| 2024-07-09 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
5,931 |
$6.66 |
$39.5K |
444,683 |
| 2024-07-05 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
12,342 |
$7.06 |
$87.13K |
450,614 |
| 2024-07-03 |
Morisset Valerie |
EVP, R&d and CSO |
Vente Informative |
50,000 |
$6.76 |
$338K |
462,956 |
| 2024-07-01 |
Morisset Valerie |
EVP, R&d and CSO |
Exercice d'Options (Vente) |
7,649 |
$0.00 |
$1.53 |
10,198 |
| 2024-06-27 |
Brennan Aoife |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-06-27 |
Brennan Aoife |
President and CEO |
Attribution de RSU |
275,000 |
- |
- |
275,000 |
| 2024-06-27 |
Thomas Stephen Basil |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-06-27 |
Thomas Stephen Basil |
Director |
Attribution de RSU |
100,375 |
- |
- |
100,375 |
| 2024-06-27 |
Ra Capital Management, L.p. |
10 Percent Owner |
Attribution de RSU |
1,807,000 |
- |
- |
1,807,000 |
| 2024-06-26 |
Ra Capital Management, L.p. |
10 Percent Owner |
Attribution de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Ratcliffe Liam |
Director |
Attribution de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Dunn Judith |
Director |
Attribution de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Rosenberg Adam Joseph |
Director |
Attribution de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Tate Simon |
Director |
Attribution de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Levin Andrew David |
Executive Chairman |
Attribution de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-20 |
Pimblett Emily |
Chief Accounting Officer |
Vente Informative |
1,245 |
$7.21 |
$8.98K |
3,755 |
| 2024-06-18 |
Pimblett Emily |
Chief Accounting Officer |
Exercice d'Options |
5,000 |
- |
- |
5,000 |
| 2024-04-05 |
Morisset Valerie |
EVP, R&d and CSO |
Exercice d'Options (Vente) |
17,847 |
$0.00 |
$3.57 |
28,046 |
| 2024-03-18 |
Pimblett Emily |
Chief Accounting Officer |
Exercice d'Options |
40,000 |
- |
- |
40,000 |
| 2023-09-20 |
Morisset Valerie |
EVP, R&d and CSO |
Exercice d'Options (Vente) |
5,431 |
$0.00 |
$10.86 |
- |
| 2023-05-18 |
Ra Capital Management, L.p. |
10 Percent Owner |
Attribution de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Ratcliffe Liam |
Director |
Attribution de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Dunn Judith |
Director |
Attribution de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Rosenberg Adam Joseph |
Director |
Attribution de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Tate Simon |
Director |
Attribution de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Levin Andrew David |
Executive Chairman |
Attribution de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-03-13 |
Pimblett Emily |
Chief Accounting Officer |
Cession |
30,000 |
$3.27 |
$98.1K |
- |
| 2023-03-10 |
Morisset Valerie |
EVP, R&d and CSO |
Exercice d'Options (Vente) |
255,219 |
$0.00 |
$510.44 |
5,431 |
| 2022-10-31 |
Azelby Robert |
President & CEO |
Attribution de RSU |
500,000 |
- |
- |
500,000 |
| 2022-10-31 |
Bucher James B |
EVP and General Counsel |
Attribution de RSU |
95,000 |
- |
- |
95,000 |
| 2022-10-31 |
Lavelle Erin |
COO & CFO |
Attribution de RSU |
170,000 |
- |
- |
170,000 |
| 2022-10-31 |
Morisset Valerie |
EVP, R&d and CSO |
Attribution de RSU |
170,000 |
- |
- |
170,000 |
| 2022-05-19 |
Patterson Leone D |
Director |
Attribution de RSU |
10,000 |
$3.46 |
$34.6K |
10,000 |
| 2022-05-19 |
Ra Capital Management, L.p. |
10 Percent Owner |
Attribution de RSU |
10,000 |
$3.46 |
$34.6K |
10,000 |
| 2022-05-19 |
Ratcliffe Liam |
Director |
Attribution de RSU |
10,000 |
$3.46 |
$34.6K |
10,000 |
| 2022-05-19 |
Shah Rajeev M. |
Director |
Attribution de RSU |
10,000 |
- |
- |
10,000 |
| 2022-05-19 |
Dunn Judith |
Director |
Attribution de RSU |
10,000 |
- |
- |
10,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
